Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities.

Casey AE, Sinha A, Singhania R, Livingstone J, Waterhouse P, Tharmapalan P, Cruickshank J, Shehata M, Drysdale E, Fang H, Kim H, Isserlin R, Bailey S, Medina T, Deblois G, Shiah YJ, Barsyte-Lovejoy D, Hofer S, Bader G, Lupien M, Arrowsmith C, Knapp S, De Carvalho D, Berman H, Boutros PC, Kislinger T, Khokha R.

J Cell Biol. 2018 Aug 6;217(8):2951-2974. doi: 10.1083/jcb.201804042. Epub 2018 Jun 19.

2.

The Transcriptional Repressor Polycomb Group Factor 6, PCGF6, Negatively Regulates Dendritic Cell Activation and Promotes Quiescence.

Boukhaled GM, Cordeiro B, Deblois G, Dimitrov V, Bailey SD, Holowka T, Domi A, Guak H, Chiu HH, Everts B, Pearce EJ, Lupien M, White JH, Krawczyk CM.

Cell Rep. 2016 Aug 16;16(7):1829-37. doi: 10.1016/j.celrep.2016.07.026. Epub 2016 Aug 4.

3.

ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer.

Deblois G, Smith HW, Tam IS, Gravel SP, Caron M, Savage P, Labbé DP, Bégin LR, Tremblay ML, Park M, Bourque G, St-Pierre J, Muller WJ, Giguère V.

Nat Commun. 2016 Jul 12;7:12156. doi: 10.1038/ncomms12156.

4.

Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network.

Samuel N, Wilson G, Id Said B, Pan A, Deblois G, Fischer NW, Alexandrova R, Casallo G, Paton T, Lupien M, Gariepy J, Merico D, Hudson TJ, Malkin D.

Oncotarget. 2016 Aug 2;7(31):49611-49622. doi: 10.18632/oncotarget.10417.

5.

Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.

Sénécal V, Deblois G, Beauseigle D, Schneider R, Brandenburg J, Newcombe J, Moore CS, Prat A, Antel J, Arbour N.

Glia. 2016 Apr;64(4):553-69. doi: 10.1002/glia.22948. Epub 2015 Dec 9.

PMID:
26649511
6.

An optimized method to process mouse CNS to simultaneously analyze neural cells and leukocytes by flow cytometry.

Legroux L, Pittet CL, Beauseigle D, Deblois G, Prat A, Arbour N.

J Neurosci Methods. 2015 May 30;247:23-31. doi: 10.1016/j.jneumeth.2015.03.021. Epub 2015 Mar 25.

PMID:
25819540
7.

ERBB2 deficiency alters an E2F-1-dependent adaptive stress response and leads to cardiac dysfunction.

Perry MC, Dufour CR, Eichner LJ, Tsang DW, Deblois G, Muller WJ, Giguère V.

Mol Cell Biol. 2014 Dec 1;34(23):4232-43. doi: 10.1128/MCB.00895-14. Epub 2014 Sep 22.

8.

Prostate cancer genetic-susceptibility locus on chromosome 20q13 is amplified and coupled to androgen receptor-regulation in metastatic tumors.

Labbé DP, Nowak DG, Deblois G, Lessard L, Giguère V, Trotman LC, Tremblay ML.

Mol Cancer Res. 2014 Feb;12(2):184-9. doi: 10.1158/1541-7786.MCR-13-0477. Epub 2013 Dec 30.

9.

PGC-1α supports glutamine metabolism in breast cancer.

McGuirk S, Gravel SP, Deblois G, Papadopoli DJ, Faubert B, Wegner A, Hiller K, Avizonis D, Akavia UD, Jones RG, Giguère V, St-Pierre J.

Cancer Metab. 2013 Dec 5;1(1):22. doi: 10.1186/2049-3002-1-22.

10.

β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.

Schade B, Lesurf R, Sanguin-Gendreau V, Bui T, Deblois G, O'Toole SA, Millar EK, Zardawi SJ, Lopez-Knowles E, Sutherland RL, Giguère V, Kahn M, Hallett M, Muller WJ.

Cancer Res. 2013 Jul 15;73(14):4474-87. doi: 10.1158/0008-5472.CAN-12-3925. Epub 2013 May 29.

11.

The PGC-1/ERR signaling axis in cancer.

Deblois G, St-Pierre J, Giguère V.

Oncogene. 2013 Jul 25;32(30):3483-90. doi: 10.1038/onc.2012.529. Epub 2012 Dec 3. Review.

PMID:
23208510
12.

Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond.

Deblois G, Giguère V.

Nat Rev Cancer. 2013 Jan;13(1):27-36. doi: 10.1038/nrc3396. Epub 2012 Nov 29. Review.

PMID:
23192231
13.

A cluster of transfusion-associated babesiosis in extremely low birthweight premature infants.

Kumar P, Marshall BC, deBlois G, Koch WC.

J Perinatol. 2012 Sep;32(9):731-3. doi: 10.1038/jp.2012.33.

PMID:
22931962
14.

Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets.

Grilley-Olson JE, Hayes DN, Moore DT, Leslie KO, Wilkerson MD, Qaqish BF, Hayward MC, Cabanski CR, Yin X, Socinski MA, Stinchcombe TE, Thorne LB, Allen TC, Banks PM, Beasley MB, Borczuk AC, Cagle PT, Christensen R, Colby TV, Deblois GG, Elmberger G, Graziano P, Hart CF, Jones KD, Maia DM, Miller CR, Nance KV, Travis WD, Funkhouser WK.

Arch Pathol Lab Med. 2013 Jan;137(1):32-40. doi: 10.5858/arpa.2012-0033-OA. Epub 2012 May 14.

15.

PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer.

Lessard L, Labbé DP, Deblois G, Bégin LR, Hardy S, Mes-Masson AM, Saad F, Trotman LC, Giguère V, Tremblay ML.

Cancer Res. 2012 Mar 15;72(6):1529-37. doi: 10.1158/0008-5472.CAN-11-2602. Epub 2012 Jan 26.

16.

Cancer: Reprogramming clinical outcome.

Deblois G, Giguère V.

Nature. 2012 Jan 18;481(7381):275-6. doi: 10.1038/481275a. No abstract available.

PMID:
22258604
17.

Estrogen-related receptor α, the molecular clock, and transcriptional control of metabolic outputs.

Giguère V, Dufour CR, Eichner LJ, Deblois G, Cermakian N.

Cold Spring Harb Symp Quant Biol. 2011;76:57-61. doi: 10.1101/sqb.2011.76.011031. Epub 2011 Dec 16. Review.

PMID:
22179984
18.

Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease.

Deblois G, Giguère V.

Biochim Biophys Acta. 2011 Aug;1812(8):1032-40. doi: 10.1016/j.bbadis.2010.12.009. Epub 2010 Dec 21. Review.

19.

Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis.

Deblois G, Chahrour G, Perry MC, Sylvain-Drolet G, Muller WJ, Giguère V.

Cancer Res. 2010 Dec 15;70(24):10277-87. doi: 10.1158/0008-5472.CAN-10-2840. Epub 2010 Oct 20. Erratum in: Cancer Res. 2011 Feb 15;71(4):1508.

20.

An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha.

Wilson BJ, Tremblay AM, Deblois G, Sylvain-Drolet G, Giguère V.

Mol Endocrinol. 2010 Jul;24(7):1349-58. doi: 10.1210/me.2009-0441. Epub 2010 May 19.

21.

Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.

Deblois G, Hall JA, Perry MC, Laganière J, Ghahremani M, Park M, Hallett M, Giguère V.

Cancer Res. 2009 Aug 1;69(15):6149-57. doi: 10.1158/0008-5472.CAN-09-1251. Epub 2009 Jul 21.

22.

Nuclear receptor location analyses in mammalian genomes: from gene regulation to regulatory networks.

Deblois G, Giguère V.

Mol Endocrinol. 2008 Sep;22(9):1999-2011. doi: 10.1210/me.2007-0546. Epub 2008 Feb 21. Review.

23.

Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression.

Blanchette M, Bataille AR, Chen X, Poitras C, Laganière J, Lefèbvre C, Deblois G, Giguère V, Ferretti V, Bergeron D, Coulombe B, Robert F.

Genome Res. 2006 May;16(5):656-68. Epub 2006 Apr 10.

24.

From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.

Laganière J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguère V.

Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11651-6. Epub 2005 Aug 8.

25.

Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.

Laganière J, Deblois G, Giguère V.

Mol Endocrinol. 2005 Jun;19(6):1584-92. Epub 2005 Apr 14.

PMID:
15831516
26.

Estrogen-related receptor alpha (ERRalpha) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine.

Carrier JC, Deblois G, Champigny C, Levy E, Giguère V.

J Biol Chem. 2004 Dec 10;279(50):52052-8. Epub 2004 Oct 4.

27.

Nuclear receptor target gene discovery using high-throughput chromatin immunoprecipitation.

Laganière J, Deblois G, Giguère V.

Methods Enzymol. 2003;364:339-50. No abstract available.

PMID:
14631854
28.

Ligand-independent coactivation of ERalpha AF-1 by steroid receptor RNA activator (SRA) via MAPK activation.

Deblois G, Giguère V.

J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):123-31.

PMID:
12943696
29.
30.
31.

Hemispherical spondylosclerosis: MR appearance.

Jensen ME, Hayes CW, DeBlois GG, Laine FJ.

J Comput Assist Tomogr. 1989 May-Jun;13(3):540-2.

PMID:
2723196
32.

Computed tomography of benign mesenchymoma of the neck.

Darwin RH, Laine FJ, deBlois GG, Walsh JW.

J Comput Assist Tomogr. 1989 May-Jun;13(3):514-6.

PMID:
2723188
33.

Cardiorespiratory and cellular changes with interleukin 2 infusion in sheep.

Glauser FL, Bechard DE, DeBlois GG, Fowler AA, Merchant RE, Jesmok G, Fairman RP.

J Appl Physiol (1985). 1989 Jan;66(1):128-34.

PMID:
2783928
34.

Cardiopulmonary toxicity of adoptive immunotherapy.

Glauser FL, DeBlois G, Bechard D, Fowler AA, Merchant R, Fairman RP.

Am J Med Sci. 1988 Dec;296(6):406-12. Review.

PMID:
3063115
35.

A comparison of the cardiopulmonary effects of continuous versus bolus infusion of recombinant interleukin-2 in sheep.

Glauser FL, DeBlois GG, Bechard DE, Merchant RE, Grant AJ, Fowler AA, Fairman RP.

Cancer Res. 1988 Apr 15;48(8):2221-5.

36.

Cardiopulmonary effects of recombinant interleukin-2 infusion in sheep.

Glauser FL, DeBlois GG, Bechard DE, Merchant RE, Grant AJ, Fowler AA, Fairman RP.

J Appl Physiol (1985). 1988 Mar;64(3):1030-7.

PMID:
3259225
37.

Effects of protamine, heparinase, and hyaluronidase on endothelial permeability and surface charge.

Sunnergren KP, Fairman RP, deBlois GG, Glauser FL.

J Appl Physiol (1985). 1987 Nov;63(5):1987-92.

PMID:
3693232
38.

Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function.

Irani AM, Craig SS, DeBlois G, Elson CO, Schechter NM, Schwartz LB.

J Immunol. 1987 Jun 15;138(12):4381-6.

PMID:
3295046
39.

The major enzymes of human mast cell secretory granules.

Schwartz LB, Bradford TR, Irani AM, Deblois G, Craig SS.

Am Rev Respir Dis. 1987 May;135(5):1186-9. Review. No abstract available.

PMID:
3555191
40.

Fatal pulmonary fibrosis from low-dose bleomycin therapy.

Bechard DE, Fairman RP, DeBlois GG, Via CT.

South Med J. 1987 May;80(5):646-9.

PMID:
2437659
42.

Two types of human mast cells that have distinct neutral protease compositions.

Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB.

Proc Natl Acad Sci U S A. 1986 Jun;83(12):4464-8.

44.
45.

Cerebral fat embolism following cardiac surgery.

Ghatak NR, Sinnenberg RJ, deBlois GG.

Stroke. 1983 Jul-Aug;14(4):619-21.

PMID:
6658941
46.

Clostridium paraputrificum bacteremia associated with aspiration pneumonia.

Nachamkin I, DeBlois GE, Dalton HP.

South Med J. 1982 Aug;75(8):1023-4. No abstract available.

PMID:
7112187
47.

[Anatomo-clinical characteristics of 349 resected esophageal cancers].

Maillard JN, Huguier M, Conte-Marti J, Deblois G, Lortat-Jacob JL.

Presse Med. 1971 Mar 20;79(14):617-9. French. No abstract available.

PMID:
5552969
48.

Revue Des Livres.

Flament J, Deblois G, Burny F, Enderlé J, Koster.

Acta Clin Belg. 1967 Jan;22(6):381-384. No abstract available.

PMID:
27351786
49.

[Surgical treatment of gastric cancer].

Van Geertruyden J, Kiekens R, Deblois G, Desneux JJ.

Bull Acad R Med Belg. 1966;6(11):653-85. French. No abstract available.

PMID:
5984255
50.

[Oxygen consumption by the human placenta "in vitro". The experimental conditions].

GHILAIN A, DEBLOIS G.

Bull Soc R Belge Gynecol Obstet. 1961;31:409-26. French. No abstract available.

PMID:
13898198

Supplemental Content

Loading ...
Support Center